[Matrix metalloproteinases and their tissue inhibitors in basal cell and metatypical cancer of the skin].
10 cases of ulcerative-nodular basal cell carcinoma and 10 cases of metatypical carcinoma of the skin were studied immunohistochemically for immunoexpression of matrix metalloproteinases (MMP-1, MMP-9) and their endogenic tissue inhibitors (TIMP-1, TIMP-2) in combination with PCNA, p53 tumor complexes. Some differences are found in these types of tumors.
Snarskaia
E S
ES
Molochkov
V A
VA
Frank
G A
GA
Zavalishina
L A
LA
D002280:Basal Cell Carcinoma / Q000175:diagnosis* / Q000201:enzymology / Q000276:immunology; D003937:Diagnosis, Differential; D006801:Humans; D020781:Matrix Metalloproteinase 1 / Q000032:analysis*; D020780:Matrix Metalloproteinase 9 / Q000032:analysis*; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000201:enzymology / Q000276:immunology; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000032:analysis; D019716:Tissue Inhibitor of Metalloproteinase-2 / Q000032:analysis; D019714:Tissue Inhibitor of Metalloproteinases / Q000032:analysis*; D016159:Tumor Suppressor Protein p53 / Q000032:analysis
D018809:Proliferating Cell Nuclear Antigen; D019715:Tissue Inhibitor of Metalloproteinase-1; D019714:Tissue Inhibitor of Metalloproteinases; D016159:Tumor Suppressor Protein p53; D019716:Tissue Inhibitor of Metalloproteinase-2; D020780:Matrix Metalloproteinase 9; D020781:Matrix Metalloproteinase 1